Evidence map›Paper›PMID 32766398›Full record

ArticleThe archives of bone and joint surgery2020

The Survival and Incidence Rate of Ewing Sarcoma; a National Population-based Study in Iran (2008-2015).

Adel Ebrahimpour, Mohammadreza Chehrassan, Mehrdad Sadighi, Mehdi Azizmohammad Looha, Amin Karimi, Atieh Akbari, Alireza Raeisi, Mohammad Esmaeil Akbari

Abstract read
In one paragraph

Article in The archives of bone and joint surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adel EbrahimpourCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammadreza ChehrassanCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mehrdad SadighiCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mehdi Azizmohammad LoohaDepartment of iostatics, Faculty of aramedical ciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amin KarimiDepartment of Orthopedic Surgery, Taleghani Hospital, Shahid Beheshti University of Medical Sciences.
Atieh AkbariCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Alireza RaeisiShiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Esmaeil AkbariCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effect of race and ethnicity on some kind of malignant bone tumors including Ewing sarcoma has been proven in different studies. In order to evaluate the latter, national cancer registries may help to increase understanding about potential cancer causes, prevention and control strategies, and apply these findings to control health problems among populations with similar characteristics.

methodsA national population-based cancer registry study based on all patients affected by Ewing Sarcoma was registered in the Iran National Cancer Registry (INCR) between 2008 and 2015 was designed. Demographic data of microscopically confirmed cases of bone Ewing sarcoma were registered. Patients with Ewing sarcoma were divided in groups to describe the primary site of the tumor (including axial or appendicular bones) and analyzed. In order to analyze the survival rate, randomized selection of the patient through the INCR data-base was performed.

resultsA total of 678 cases of malignant Ewing sarcoma of the bone were identified through the INCR. The mean age of Ewing sarcoma in Iran was 21.53 years. Nearly half of patients were observed at the age group of 15-24. The total crude incidence rate of Ewing sarcoma was 1.29 in 1 million. The mean 5 year survival rate was 47%. The Mean survival rate for study population was 5.53.

conclusionThe crude incidence rate of Ewing sarcoma in Iran is relatively lower with respect to other registries. The majority of patients are in 15-25 years group and shows affection by Ewing sarcoma in an older age. Socioeconomic factors had direct influence on survival rate.

Indexed as

Ewing sarcomaMalignant bone tumorsSarcoma

Identifiers

PMID32766398
PMCPMC7358229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.